Chapman Arlene B, Guay-Woodford Lisa M, Grantham Jared J, Torres Vicente E, Bae Kyongtae T, Baumgarten Deborah A, Kenney Philip J, King Bernard F, Glockner James F, Wetzel Louis H, Brummer Marijn E, O'Neill W Charles, Robbin Michelle L, Bennett William M, Klahr Saulo, Hirschman Gladys H, Kimmel Paul L, Thompson Paul A, Miller J Philip
Department of Medicine (Renal Division), University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kidney Int. 2003 Sep;64(3):1035-45. doi: 10.1046/j.1523-1755.2003.00185.x.
Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by gradual renal enlargement and cyst growth prior to loss of renal function. Standard radiographic imaging has not provided the resolution and accuracy necessary to detect small changes in renal volume or to reliably measure renal cyst volumes. The Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) is longitudinally observing ADPKD individuals using high-resolution magnetic resonance (MR) imaging to determine if change in renal and cyst volumes can be detected over a short period of time, and if they correlate with decline in renal function early in disease.
Standardization studies were conducted in phantoms and four subjects at each participating clinical center. After, in the full-scale protocol, healthy ADPKD individuals 15 to 45 years old with creatinine clearance>70 mL/min underwent standardized MR renal imaging, renal iothalamate clearance, comprehensive clinical evaluation, and determination of 24-hour urinary albumin and electrolyte excretion. Stereology was used from T1-weighted images to quantify renal volume, and region-growing thresholding was used from T2-weighted images to determine cyst volume. Renal structures were evaluated in relation to demographic, clinical, and biochemical variables using means/medians, standard deviations, and Pearson correlations.
Reliability coefficients for MR renal and cyst volume measurements in phantoms were 99.9% and 89.2%, respectively. In the full-scale protocol, 241 ADPKD individuals (145 women and 96 men) were enrolled. Total renal, cyst, and % cyst volume were significantly greater in each decade group. Hypertensive individuals demonstrated greater renal, cyst, and % cyst volume than normotensive subjects. Age-adjusted renal (r = -0.31, P < 0.0001), cyst (r = -0.36, P < 0.0001), and % cyst volume (r = -0.35, P < 0.0001) were inversely related to glomerular filtration rate (GFR). Age-adjusted renal volume (r = 0.42, P < 0.0001), cystic (r = 0.39, P < 0.0001, and % cyst volume (r = 0.41, P < 0.0001) were related with urinary albumin excretion.
MR measures of renal and cyst volume are reliable and accurate in patients with ADPKD. ADPKD is characterized by significant cystic involvement that increases with age. Structure (renal and cyst volume) and function (GFR) are inversely related and directly related with the presence of hypertension and urinary albumin excretion in individuals with normal renal function.
常染色体显性多囊肾病(ADPKD)的特征是在肾功能丧失之前肾脏逐渐增大和囊肿生长。标准的放射影像学检查未能提供检测肾脏体积微小变化或可靠测量肾囊肿体积所需的分辨率和准确性。多囊肾病放射影像学研究联盟(CRISP)正在对ADPKD患者进行纵向观察,使用高分辨率磁共振(MR)成像来确定在短时间内是否可以检测到肾脏和囊肿体积的变化,以及它们是否与疾病早期肾功能下降相关。
在每个参与的临床中心对模型和四名受试者进行了标准化研究。之后,在全面方案中,15至45岁、肌酐清除率>70 mL/min的健康ADPKD个体接受了标准化的肾脏MR成像、碘他拉酸盐肾脏清除率测定、全面的临床评估以及24小时尿白蛋白和电解质排泄测定。利用T1加权图像的体视学方法量化肾脏体积,利用T2加权图像的区域生长阈值法确定囊肿体积。使用均值/中位数、标准差和Pearson相关性评估肾脏结构与人口统计学、临床和生化变量之间的关系。
模型中肾脏和囊肿体积MR测量的可靠性系数分别为99.9%和89.2%。在全面方案中,纳入了241名ADPKD个体(145名女性和96名男性)。每个十年组的总肾体积、囊肿体积和囊肿体积百分比均显著更大。高血压个体的肾脏、囊肿和囊肿体积百分比均高于血压正常的受试者。年龄校正后的肾脏体积(r = -0.31,P < 0.0001)、囊肿体积(r = -0.36,P < 0.0001)和囊肿体积百分比(r = -0.35,P < 0.0001)与肾小球滤过率(GFR)呈负相关。年龄校正后的肾脏体积(r = 0.42,P < 0.0001)、囊肿体积(r = 0.39,P < 0.0001)和囊肿体积百分比(r = 0.41,P < 0.0001)与尿白蛋白排泄相关。
ADPKD患者肾脏和囊肿体积的MR测量可靠且准确。ADPKD的特征是随着年龄增长囊肿显著受累。在肾功能正常的个体中,结构(肾脏和囊肿体积)与功能(GFR)呈负相关,与高血压和尿白蛋白排泄的存在呈正相关。